Latest market price
19.53
-0.01-0.05%
OverviewShort InterestFilings
ODTXQT34Odyssey Therapeutics, Inc.·NASDAQ
19.53-0.05%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 20, 20268-KCurrent report
Sep 09, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jun 23, 20268-KCurrent report
Jun 17, 20268-KCurrent report
Jun 17, 202610-QQuarterly report
Jun 05, 2026SC 13GBeneficial ownership statement (passive)
May 18, 2026SC 13DBeneficial ownership statement (active)
May 18, 2026SC 13DBeneficial ownership statement (active)
May 18, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13DBeneficial ownership statement (active)
May 15, 2026SC 13DBeneficial ownership statement (active)
May 13, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 12, 20263Initial statement of beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 11, 2026S-8Registration of employee benefit securities
May 11, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
#1 / 25 of 69
Page
▼
/ 3